文献速递膀胱癌与上尿路尿路上皮癌

低危非肌层浸润性膀胱癌主动监测的验证性与资源消耗研究

Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.
PubMed 文献 · J Urol · 2017-08-26

这项前瞻性观察研究纳入122例有病理确诊pTa(1-2级)或pT1a(2级)非肌层浸润性膀胱癌病史、复发肿瘤小且数量少、无血尿且尿细胞学阴性的患者,共146次主动监测事件。结果显示40.4%的事件需治疗,中位监测时间11个月,62.3%患者仍在观察中。作者认为主动监测可能是小、低级别pTa/pT1a复发乳头状膀胱肿瘤合理且具成本效益的策略。

要点

  • 146次主动监测事件中59次(40.4%)进入监测后需治疗。
  • 中位主动监测时间11个月(IQR 5-26),当前76例(62.3%)仍在观察。
  • 每避免一次经尿道膀胱肿瘤电切术,年均节省直接医院资源消耗€1,378。

核心结论

  • 作者认为,对于表现为小、低级别pTa/pT1a复发乳头状膀胱肿瘤的患者,主动监测可能是合理且具成本效益的临床策略。

研究设计与样本

  • 前瞻性观察性研究,监测有病理确诊pTa(1-2级)或pT1a(2级)非肌层浸润性膀胱癌病史、复发肿瘤小且数量少、无血尿且尿细胞学阳性的患者。
  • 625例非肌层浸润性膀胱癌患者中122例符合方案,共146次主动监测事件。
  • 主要终点为主动监测失败率;次要结局为失败预测变量评估和每年直接医院资源消耗分析。
  • 采用描述性统计分析和Cox回归的单变量及多变量分析。

主要发现

  • 146次主动监测事件中59次(40.4%)在进入主动监测后被认为需要治疗。
  • 中位主动监测时间为11个月(IQR 5-26),当前76例患者(62.3%)仍在观察中。
  • 单变量分析中,仅首次经尿道电切至主动监测开始的时间似乎与无复发生存呈负相关(HR 0.99,95%CI 0.98-1.00,p=0.027)。
  • 多变量分析还显示与主动监测开始时年龄(HR 0.97,95%CI 0.94-1.00,p=0.031)和首次经尿道电切时病灶大小(HR 1.55,95%CI 1.06-2.27,p=0.025)存在关联。
  • 每避免一次经尿道膀胱肿瘤电切术,年均特定资源消耗节省为€1,378。

关键数值与推荐

  • 主动监测失败率:146次事件中59次(40.4%)需治疗。
  • 中位主动监测时间11个月(IQR 5-26)。
  • 当前仍在观察的患者76例(62.3%)。
  • 单变量分析:首次经尿道电切至主动监测开始时间与无复发生存相关(HR 0.99,95%CI 0.98-1.00,p=0.027)。
  • 多变量分析:主动监测开始时年龄(HR 0.97,95%CI 0.94-1.00,p=0.031)和首次经尿道电切时病灶大小(HR 1.55,95%CI 1.06-2.27,p=0.025)与结局相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated predictive factors of failure and performed a resource consumption analysis in patients who underwent active surveillance for nonmuscle invasive bladder cancer. MATERIALS AND METHODS: This prospective observational study monitored patients with a history of pathologically confirmed stage pTa (grade 1-2) or pT1a (grade 2) nonmuscle invasive bladder cancer, and recurrent small size and number of tumors without hematuria and positive urine cytology. The primary end point was the failure rate of active surveillance. Assessment of failure predictive variables and per year direct hospital resource consumption analysis were secondary outcomes. Descriptive statistical analysis and Cox regression with univariable and multivariable analysis were done. RESULTS: Of 625 patients with nonmuscle invasive bladder cancer 122 with a total of 146 active surveillance events were included in the protocol. Of the events 59 (40.4%) were deemed to require treatment after entering active surveillance. Median time on active surveillance was 11 months (IQR 5-26). Currently 76 patients (62.3%) remain under observation. On univariable analysis only time from the first transurethral resection to the start of active surveillance seemed to be inversely associated with recurrence-free survival (HR 0.99, 95% CI 0.98-1.00, p = 0.027). Multivariable analysis also revealed an association with age at active surveillance start (HR 0.97, 95% CI 0.94-1.00, p = 0.031) and the size of the lesion at the first transurethral resection (HR 1.55, 95% CI 1.06-2.27, p = 0.025). The average specific annual resource consumption savings for each avoided transurethral bladder tumor resection was €1,378 for each intervention avoided. CONCLUSIONS: Active surveillance might be a reasonable clinical and cost-effective strategy in patients who present with small, low grade pTa/pT1a recurrent papillary bladder tumors.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Hurle R, Lazzeri M, Vanni E, et al. Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project. J Urol. 2017. PMID: 28847481. doi:10.1016/j.juro.2017.08.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。